James Investment Research’s Aetna Inc AET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-63,155
Closed -$12.8M 922
2018
Q3
$12.8M Sell
63,155
-6,518
-9% -$1.27M 0.53% 41
2018
Q2
$12.8M Sell
69,673
-6,909
-9% -$1.23M 0.49% 47
2018
Q1
$12.9M Sell
76,582
-5,458
-7% -$981K 0.49% 48
2017
Q4
$14.8M Sell
82,040
-12,975
-14% -$2.23M 0.51% 45
2017
Q3
$15.1M Buy
95,015
+13,763
+17% +$2.15M 0.51% 51
2017
Q2
$12.3M Sell
81,252
-57,983
-42% -$8.2M 0.38% 73
2017
Q1
$17.8M Sell
139,235
-18,944
-12% -$2.38M 0.5% 65
2016
Q4
$19.6M Sell
158,179
-118,923
-43% -$14.2M 0.51% 62
2016
Q3
$32M Sell
277,102
-193,256
-41% -$22.7M 0.85% 34
2016
Q2
$57.4M Sell
470,358
-193,246
-29% -$22.2M 1.45% 12
2016
Q1
$74.6M Buy
663,604
+49,350
+8% +$5.28M 1.82% 6
2015
Q4
$66.4M Buy
614,254
+21,143
+4% +$2.29M 1.64% 10
2015
Q3
$64.9M Buy
593,111
+121,211
+26% +$14M 1.73% 10
2015
Q2
$60.1M Buy
471,900
+86,544
+22% +$9.88M 1.4% 13
2015
Q1
$41.1M Buy
385,356
+178,487
+86% +$17.5M 0.97% 31
2014
Q4
$18.4M Buy
206,869
+205,779
+18,879% +$17.3M 0.5% 67
2014
Q3
$88K Buy
+1,090
New +$88.7K ﹤0.01% 365

Other funds holding AET

James Investment Research's AET Position: Q4 2018 in Review

James Investment Research sold out of Aetna Inc (AET) in Q4 2018, closing a stake of 63,155 shares — an estimated $12.8M sold.

James Investment Research first reported a position in AET in Q3 2014 and held it in 17 quarters. The position peaked at $74.6M in Q1 2016. 6 funds tracked by Wall St. Rank hold AET as of Q4 2018.

  • James Investment Research reported no remaining Aetna Inc position as of Q4 2018 after selling out during the quarter.
  • James Investment Research sold 63,155 Aetna Inc shares in Q4 2018, an estimated $12.8M.
  • James Investment Research first reported a position in Aetna Inc in Q3 2014 and held it in 17 quarters.
  • James Investment Research's Aetna Inc position peaked at $74.6M in Q1 2016.
  • 6 funds tracked by Wall St. Rank held Aetna Inc as of Q4 2018.

Based on James Investment Research's 13F filing for Q4 2018, filed 22 Jan 2019.